Zychrome® brand chromium dinicocysteinate is a unique, patent-pending, chromium complex. Preliminary clinical data of a 90-day, randomized, double-blind, placebo-controlled study conducted in the United States suggests that Zychrome® supports normal insulin sensitivity, activity and levels trending toward normal range, compared to baseline.*
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.